BridgeBio Pharma, Inc.
US ˙ NasdaqGS ˙ US10806X1028

SecurityBBIO / BridgeBio Pharma, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership3,173,940 shares
Latest Disclosed Value $ 235,696,785
Citadel Advisors Llc ownership in BBIO / BridgeBio Pharma, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 3,173,940 shares of BridgeBio Pharma, Inc. (US:BBIO) valued at $235,696,784 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 698,182 shares of BridgeBio Pharma, Inc.. This represents a change in shares of 354.60% during the quarter. The current value of the position is $214,590,083 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (BBIO) in the form of stock options. The firm currently holds call options representing 161,600 of underlying shares valued at $12,000,416 USD and put options representing 54,700 of underlying shares valued at $4,062,022 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BBIO / BridgeBio Pharma, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BRIDGEBIO PHARMA COM 10806X102 3,173,940 2,475,758 354.60 235,697 341.35 0.0335
2026-02-17 2025-12-31 13F BRIDGEBIO PHARMA COM 10806X102 698,182 698,182 53,404 0.0080
2025-11-14 2025-09-30 13F BRIDGEBIO PHARMA COM 10806X102 0 -332,325 -100.00 0 -100.00
2025-08-14 2025-06-30 13F BRIDGEBIO PHARMA COM 10806X102 332,325 -2,598,708 -88.66 14,350 -85.84 0.0025
2025-05-15 2025-03-31 13F BRIDGEBIO PHARMA COM 10806X102 2,931,033 1,675,672 133.48 101,326 194.15 0.0192
2025-02-14 2024-12-31 13F BRIDGEBIO PHARMA COM 10806X102 1,255,361 -1,686,753 -57.33 34,447 -54.01 0.0060
2024-11-14 2024-09-30 13F BRIDGEBIO PHARMA COM 10806X102 2,942,114 785,665 36.43 74,906 37.14 0.0145
2024-08-14 2024-06-30 13F BRIDGEBIO PHARMA COM 10806X102 2,156,449 1,273,174 144.14 54,623 100.01 0.0111
2024-05-15 2024-03-31 13F BRIDGEBIO PHARMA COM 10806X102 883,275 219,120 32.99 27,311 1.86 0.0053
2024-02-14 2023-12-31 13F BRIDGEBIO PHARMA COM 10806X102 664,155 95,495 16.79 26,812 78.80 0.0054
2023-11-14 2023-09-30 13F BRIDGEBIO PHARMA COM 10806X102 568,660 155,050 37.49 14,996 110.78 0.0032
2023-08-14 2023-06-30 13F BRIDGEBIO PHARMA COM 10806X102 413,610 126,878 44.25 7,114 49.64 0.0015
2023-05-15 2023-03-31 13F BRIDGEBIO PHARMA COM 10806X102 286,732 -2,590,456 -90.03 4,754 -78.32 0.0010
2023-02-14 2022-12-31 13F BRIDGEBIO PHARMA COM 10806X102 2,877,188 1,066,176 58.87 21,924 21.79 0.0051
2022-11-14 2022-09-30 13F BRIDGEBIO PHARMA COM 10806X102 1,811,012 969,218 115.14 18,002 135.50 0.0041
2022-08-15 2022-06-30 13F BRIDGEBIO PHARMA COM 10806X102 841,794 455,732 118.05 7,644 95.05 0.0020
2022-05-16 2022-03-31 13F BRIDGEBIO PHARMA COM 10806X102 386,062 386,062 3,919 0.0008
2022-02-14 2021-12-31 13F BRIDGEBIO PHARMA Cmn 10806X102 0 -342,548 -100.00 0 -100.00
2021-11-15 2021-09-30 13F BRIDGEBIO PHARMA Cmn 10806X102 342,548 -70,030 -16.97 16,055 -36.16 0.0033
2021-08-16 2021-06-30 13F BRIDGEBIO PHARMA COM 10806X102 412,578 227,093 122.43 25,150 120.13 0.0056
2021-05-21 2021-03-31 13F/A-1 BRIDGEBIO PHARMA COM 10806X102 185,485 -48,798 -20.83 11,425 -31.42 0.0028
2021-05-17 2021-03-31 13F BRIDGEBIO PHARMA COM 10806X102 185,485 -48,798 11,425 0.0028
2021-02-16 2020-12-31 13F BRIDGEBIO PHARMA COM 10806X102 234,283 120,665 106.20 16,660 290.80 0.0043
2020-11-16 2020-09-30 13F BRIDGEBIO PHARMA COM 10806X102 113,618 66,634 141.82 4,263 178.26 0.0012
2020-08-14 2020-06-30 13F BRIDGEBIO PHARMA Cmn 10806X102 46,984 14,616 45.16 1,532 63.15 0.0005
2020-05-15 2020-03-31 13F BRIDGEBIO PHARMA Cmn 10806X102 32,368 10,087 45.27 939 56.24 0.0004
2019-08-14 2019-06-30 13F BRIDGEBIO PHARMA Cmn 10806X102 22,281 22,281 601 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BRIDGEBIO PHARMA COM Call 161,600 -63.89 12,000 -64.94 n/a n/a n/a
2026-02-17 2025-12-31 13F BRIDGEBIO PHARMA COM Call 447,500 61.38 34,229 137.67 n/a n/a n/a
2025-11-14 2025-09-30 13F BRIDGEBIO PHARMA COM Call 277,300 62.45 14,403 95.41 n/a n/a n/a
2025-08-14 2025-06-30 13F BRIDGEBIO PHARMA COM Call 170,700 -33.55 7,371 -17.01 n/a n/a n/a
2025-05-15 2025-03-31 13F BRIDGEBIO PHARMA COM Call 256,900 -32.96 8,881 -15.54 n/a n/a n/a
2025-02-14 2024-12-31 13F BRIDGEBIO PHARMA COM Call 383,200 65.53 10,515 78.43 n/a n/a n/a
2024-11-14 2024-09-30 13F BRIDGEBIO PHARMA COM Call 231,500 -26.04 5,894 -25.67 n/a n/a n/a
2024-08-14 2024-06-30 13F BRIDGEBIO PHARMA COM Call 313,000 -11.28 7,928 -27.32 n/a n/a n/a
2024-05-15 2024-03-31 13F BRIDGEBIO PHARMA COM Call 352,800 9.43 10,909 -16.19 n/a n/a n/a
2024-02-14 2023-12-31 13F BRIDGEBIO PHARMA COM Call 322,400 -1.10 13,015 51.41 n/a n/a n/a
2023-11-14 2023-09-30 13F BRIDGEBIO PHARMA COM Call 326,000 -40.54 8,597 -8.84 n/a n/a n/a
2023-08-14 2023-06-30 13F BRIDGEBIO PHARMA COM Call 548,300 130.38 9,431 138.98 n/a n/a n/a
2023-05-15 2023-03-31 13F BRIDGEBIO PHARMA COM Call 238,000 291.45 3,946 752.27 n/a n/a n/a
2023-02-14 2022-12-31 13F BRIDGEBIO PHARMA COM Call 60,800 102.67 463 55.37 n/a n/a n/a
2022-11-14 2022-09-30 13F BRIDGEBIO PHARMA COM Call 30,000 -41.97 298 -36.46 n/a n/a n/a
2022-08-15 2022-06-30 13F BRIDGEBIO PHARMA COM Call 51,700 -41.18 469 -47.42 n/a n/a n/a
2022-05-16 2022-03-31 13F BRIDGEBIO PHARMA COM Call 87,900 -83.29 892 -89.83 n/a n/a n/a
2022-02-14 2021-12-31 13F BRIDGEBIO PHARMA COM Call 526,100 1,140.80 8,775 341.62 n/a n/a n/a
2021-11-15 2021-09-30 13F BRIDGEBIO PHARMA Cmn Call 42,400 131.69 1,987 78.05 n/a n/a n/a
2021-08-16 2021-06-30 13F BRIDGEBIO PHARMA COM Call 18,300 -22.46 1,116 -23.25 n/a n/a n/a
2021-05-21 2021-03-31 13F/A BRIDGEBIO PHARMA COM Call 23,600 -62.12 1,454 -67.18 n/a n/a n/a
2021-05-17 2021-03-31 13F BRIDGEBIO PHARMA COM Call 23,600 1,454 n/a n/a n/a
2021-02-16 2020-12-31 13F BRIDGEBIO PHARMA COM Call 62,300 709.09 4,430 1,432.87 n/a n/a n/a
2020-11-16 2020-09-30 13F BRIDGEBIO PHARMA COM Call 7,700 -63.51 289 -57.99 n/a n/a n/a
2020-08-14 2020-06-30 13F BRIDGEBIO PHARMA Cmn Call 21,100 -37.57 688 -29.80 n/a n/a n/a
2020-05-15 2020-03-31 13F BRIDGEBIO PHARMA Cmn Call 33,800 980 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BRIDGEBIO PHARMA COM Put 54,700 -50.90 4,062 -52.32 n/a n/a n/a
2026-02-17 2025-12-31 13F BRIDGEBIO PHARMA COM Put 111,400 -12.70 8,521 28.56 n/a n/a n/a
2025-11-14 2025-09-30 13F BRIDGEBIO PHARMA COM Put 127,600 -29.23 6,628 -14.87 n/a n/a n/a
2025-08-14 2025-06-30 13F BRIDGEBIO PHARMA COM Put 180,300 -21.13 7,785 -1.48 n/a n/a n/a
2025-05-15 2025-03-31 13F BRIDGEBIO PHARMA COM Put 228,600 -23.80 7,903 -4.01 n/a n/a n/a
2025-02-14 2024-12-31 13F BRIDGEBIO PHARMA COM Put 300,000 30.78 8,232 40.96 n/a n/a n/a
2024-11-14 2024-09-30 13F BRIDGEBIO PHARMA COM Put 229,400 11.31 5,841 11.88 n/a n/a n/a
2024-08-14 2024-06-30 13F BRIDGEBIO PHARMA COM Put 206,100 109.24 5,221 71.43 n/a n/a n/a
2024-05-15 2024-03-31 13F BRIDGEBIO PHARMA COM Put 98,500 20.86 3,046 -7.45 n/a n/a n/a
2024-02-14 2023-12-31 13F BRIDGEBIO PHARMA COM Put 81,500 -36.77 3,290 -3.21 n/a n/a n/a
2023-11-14 2023-09-30 13F BRIDGEBIO PHARMA COM Put 128,900 -56.42 3,399 -33.18 n/a n/a n/a
2023-08-14 2023-06-30 13F BRIDGEBIO PHARMA COM Put 295,800 6.10 5,088 10.06 n/a n/a n/a
2023-05-15 2023-03-31 13F BRIDGEBIO PHARMA COM Put 278,800 1,822.76 4,623 4,101.82 n/a n/a n/a
2023-02-14 2022-12-31 13F BRIDGEBIO PHARMA COM Put 14,500 -67.05 110 -74.83 n/a n/a n/a
2022-11-14 2022-09-30 13F BRIDGEBIO PHARMA COM Put 44,000 -11.11 437 -2.67 n/a n/a n/a
2022-08-15 2022-06-30 13F BRIDGEBIO PHARMA COM Put 49,500 -36.62 449 -43.38 n/a n/a n/a
2022-05-16 2022-03-31 13F BRIDGEBIO PHARMA COM Put 78,100 -73.24 793 -83.71 n/a n/a n/a
2022-02-14 2021-12-31 13F BRIDGEBIO PHARMA COM Put 291,800 212.42 4,867 11.17 n/a n/a n/a
2021-11-15 2021-09-30 13F BRIDGEBIO PHARMA Cmn Put 93,400 10.53 4,378 -15.01 n/a n/a n/a
2021-08-16 2021-06-30 13F BRIDGEBIO PHARMA COM Put 84,500 2.92 5,151 1.86 n/a n/a n/a
2021-05-21 2021-03-31 13F/A BRIDGEBIO PHARMA COM Put 82,100 5,057 n/a n/a n/a
2021-05-17 2021-03-31 13F BRIDGEBIO PHARMA COM Put 82,100 5,057 n/a n/a n/a
2021-02-16 2020-12-31 13F BRIDGEBIO PHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-16 2020-09-30 13F BRIDGEBIO PHARMA COM Put 7,200 270 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.